Recombinant Cardiac Markers for Sustainable Growth
Scripps Laboratories is proud to share with you our unwavering and dedicated efforts to develop a comprehensive portfolio of recombinant cardiac markers. Our native markers have powered your clinical diagnostic assays for more than 35 years. We have earned your trust during this period, as we are among the largest worldwide producers of native Creatine Kinase MB (CK-MB), Myoglobin, C-Reactive Protein (CRP) and more. Now, we are focusing our decades of expertise on the production of an elite line of recombinant cardiac markers.
If your research or assay development interest is monitoring cardiac marker release profiles for the diagnosis of myocardial infarction (MI), Scripps Laboratories is developing sustainable recombinant products to assist your work: Recombinant CK-MB and Troponin T are available now and Myoglobin, Troponin I, Troponin IC Complex, and Troponin ITC Complex will be available soon. Or, if your interest is myocardial stress and assessing individuals at risk for MI, recombinant forms of CRP, Galectin-3, and NT-proBNP are in development as well.
Recombinant CK-MB and Troponin T are Available Now:
Recombinant Cardiac Markers in Development
For MI Diagnosis:
Troponin IC Complex
Troponin ITC Complex
For Risk Assessment:
Developed and produced for optimal diagnostic functionality, you can trust our recombinant cardiac markers will perform with the same reliability and precision as the native markers we’ve provided for nearly 40 years.
Contact us today for more information or to receive notification as these new products are released.